Rituximab Treatment to Block HLA Antibodies in Renal Transplant Recipients
Clinical trial NCT00261547 · WITHDRAWN
Trial details
- NCT number
- NCT00261547
- Sponsor
- Massachusetts General Hospital
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2007-11-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.